CW
MRNA icon

CreativeOne Wealth’s Moderna MRNA Stock Holding History

CreativeOne Wealth’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,821
Closed -$271K – 1188
2025
Q2 		$271K Buy
9,821
+1,040
+12% +$27.4K 0.01% 962
2025
Q1 		$249K Buy
+8,781
New +$312K 0.01% 922
2023
Q3 		– Sell
-3,344
Closed -$406K – 735
2023
Q2 		$406K Buy
3,344
+23
+0.7% +$3.07K 0.02% 556
2023
Q1 		$510K Buy
3,321
+1,682
+103% +$277K 0.03% 464
2022
Q4 		$294K Buy
+1,639
New +$268K 0.02% 576
2022
Q3 		– Sell
-1,463
Closed -$209K – 744
2022
Q2 		$209K Buy
1,463
+201
+16% +$28.7K 0.01% 669
2022
Q1 		$217K Sell
1,262
-1,251
-50% -$211K 0.01% 680
2021
Q4 		$638K Buy
2,513
+401
+19% +$117K 0.03% 388
2021
Q3 		$813K Sell
2,112
-970
-31% -$358K 0.05% 295
2021
Q2 		$724K Buy
3,082
+589
+24% +$105K 0.04% 309
2021
Q1 		$326K Buy
+2,493
New +$361K 0.02% 425

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

CreativeOne Wealth's MRNA Position: Q3 2025 in Review

CreativeOne Wealth sold out of Moderna (MRNA) in Q3 2025, closing a stake of 9,821 shares — an estimated $271K sold.

CreativeOne Wealth first reported a position in MRNA in Q1 2021 and held it in 11 quarters. The position peaked at $813K in Q3 2021. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • CreativeOne Wealth reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • CreativeOne Wealth sold 9,821 Moderna shares in Q3 2025, an estimated $271K.
  • CreativeOne Wealth first reported a position in Moderna in Q1 2021 and held it in 11 quarters.
  • CreativeOne Wealth's Moderna position peaked at $813K in Q3 2021.
  • 643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on CreativeOne Wealth's 13F filing for Q3 2025, filed 13 Nov 2025.